Mylan Prepares For US Trastuzumab Entry

Plans To Introduce Herceptin Rival ‘In A Couple Of Weeks’

 
• By Aidan Fry
  
Calendar
Mylan is preparing for the imminent launch of its Ogivri trastuzumab biosimilar in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products